UNEXPECTED MOBILISATION OF LEAD DURING CISPLATIN CHEMOTHERAPY
- 1 August 1986
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 328 (8501), 249-250
- https://doi.org/10.1016/s0140-6736(86)92072-6
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Anticancer drug pharmacodynamicsCancer Chemotherapy and Pharmacology, 1985
- In vivoX-ray fluorescence estimation of bone lead concentrations in Queensland adultsThe British Journal of Radiology, 1984
- Polarised x-rays in XRF-analysis for improved in vivo detectability of cadmium in manPhysics in Medicine & Biology, 1983
- An x-ray fluorescence technique to measure the mercury burden of dentists in vivoMedical Physics, 1981
- Feasibility Study for the in Vivo Measurement of Lead in Bone Using L-X-Ray FluorescenceIEEE Transactions on Nuclear Science, 1981
- Cisplatin (cis-diamminedichloroplatinum II)Cancer Treatment Reviews, 1979
- Cis-diamminedichloroplatinum (II)Annals of Internal Medicine, 1977
- Occupational lead nephropathyThe American Journal of Medicine, 1975
- Lead Metabolism in the Normal Human: Stable Isotope StudiesScience, 1973
- Platinum Compounds: a New Class of Potent Antitumour AgentsNature, 1969